nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.101	0.122	CbGbCtD
Idarubicin—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0873	0.105	CbGbCtD
Idarubicin—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0766	0.0922	CbGbCtD
Idarubicin—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0766	0.0922	CbGbCtD
Idarubicin—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0568	0.0684	CbGbCtD
Idarubicin—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0296	0.0356	CbGbCtD
Idarubicin—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0278	0.0335	CbGbCtD
Idarubicin—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0278	0.0335	CbGbCtD
Idarubicin—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.027	0.0325	CbGbCtD
Idarubicin—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0254	0.0306	CbGbCtD
Idarubicin—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0254	0.0306	CbGbCtD
Idarubicin—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0251	0.0303	CbGbCtD
Idarubicin—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0251	0.0303	CbGbCtD
Idarubicin—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.023	0.0277	CbGbCtD
Idarubicin—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.023	0.0277	CbGbCtD
Idarubicin—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0217	0.0261	CbGbCtD
Idarubicin—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0211	0.0254	CbGbCtD
Idarubicin—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0198	0.0239	CbGbCtD
Idarubicin—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0193	0.0232	CbGbCtD
Idarubicin—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.019	0.0229	CbGbCtD
Idarubicin—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.019	0.0229	CbGbCtD
Idarubicin—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0183	0.022	CbGbCtD
Idarubicin—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0174	0.021	CbGbCtD
Idarubicin—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0174	0.021	CbGbCtD
Idarubicin—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.00101	0.271	CbGdCrCtD
Idarubicin—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.000926	0.248	CbGdCrCtD
Idarubicin—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.000926	0.248	CbGdCrCtD
Idarubicin—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000455	0.122	CbGdCrCtD
Idarubicin—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000418	0.112	CbGdCrCtD
Idarubicin—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000387	0.00234	CcSEcCtD
Idarubicin—Infection—Abacavir—acquired immunodeficiency syndrome	0.000387	0.00234	CcSEcCtD
Idarubicin—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000386	0.00233	CcSEcCtD
Idarubicin—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000385	0.00233	CcSEcCtD
Idarubicin—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000384	0.00232	CcSEcCtD
Idarubicin—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000384	0.00232	CcSEcCtD
Idarubicin—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000382	0.0023	CcSEcCtD
Idarubicin—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00038	0.00229	CcSEcCtD
Idarubicin—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000378	0.00229	CcSEcCtD
Idarubicin—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000378	0.00228	CcSEcCtD
Idarubicin—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000378	0.00228	CcSEcCtD
Idarubicin—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00228	CcSEcCtD
Idarubicin—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000377	0.00228	CcSEcCtD
Idarubicin—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000376	0.00227	CcSEcCtD
Idarubicin—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000376	0.00227	CcSEcCtD
Idarubicin—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.00227	CcSEcCtD
Idarubicin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000373	0.00225	CcSEcCtD
Idarubicin—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.00224	CcSEcCtD
Idarubicin—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000371	0.00224	CcSEcCtD
Idarubicin—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00037	0.00224	CcSEcCtD
Idarubicin—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00223	CcSEcCtD
Idarubicin—Chills—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.0022	CcSEcCtD
Idarubicin—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000365	0.0022	CcSEcCtD
Idarubicin—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000364	0.0022	CcSEcCtD
Idarubicin—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.00219	CcSEcCtD
Idarubicin—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000362	0.00219	CcSEcCtD
Idarubicin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00036	0.00217	CcSEcCtD
Idarubicin—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00036	0.00217	CcSEcCtD
Idarubicin—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000359	0.00217	CcSEcCtD
Idarubicin—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.000359	0.00217	CcSEcCtD
Idarubicin—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.00216	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000356	0.00215	CcSEcCtD
Idarubicin—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000356	0.00215	CcSEcCtD
Idarubicin—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.00214	CcSEcCtD
Idarubicin—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000354	0.00214	CcSEcCtD
Idarubicin—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00211	CcSEcCtD
Idarubicin—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.00208	CcSEcCtD
Idarubicin—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000344	0.00208	CcSEcCtD
Idarubicin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.00208	CcSEcCtD
Idarubicin—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.00207	CcSEcCtD
Idarubicin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000342	0.00206	CcSEcCtD
Idarubicin—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000341	0.00206	CcSEcCtD
Idarubicin—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00205	CcSEcCtD
Idarubicin—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000339	0.00205	CcSEcCtD
Idarubicin—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000338	0.00204	CcSEcCtD
Idarubicin—Chills—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.00204	CcSEcCtD
Idarubicin—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000337	0.00203	CcSEcCtD
Idarubicin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000336	0.00203	CcSEcCtD
Idarubicin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000335	0.00202	CcSEcCtD
Idarubicin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000334	0.00202	CcSEcCtD
Idarubicin—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000334	0.00201	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000331	0.002	CcSEcCtD
Idarubicin—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000329	0.00198	CcSEcCtD
Idarubicin—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000328	0.00198	CcSEcCtD
Idarubicin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00198	CcSEcCtD
Idarubicin—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000327	0.00198	CcSEcCtD
Idarubicin—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00198	CcSEcCtD
Idarubicin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000325	0.00197	CcSEcCtD
Idarubicin—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.00196	CcSEcCtD
Idarubicin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000324	0.00196	CcSEcCtD
Idarubicin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00196	CcSEcCtD
Idarubicin—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00196	CcSEcCtD
Idarubicin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000323	0.00195	CcSEcCtD
Idarubicin—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000321	0.00194	CcSEcCtD
Idarubicin—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00193	CcSEcCtD
Idarubicin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00032	0.00193	CcSEcCtD
Idarubicin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000319	0.00192	CcSEcCtD
Idarubicin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000318	0.00192	CcSEcCtD
Idarubicin—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00191	CcSEcCtD
Idarubicin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.0019	CcSEcCtD
Idarubicin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000315	0.0019	CcSEcCtD
Idarubicin—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000315	0.0019	CcSEcCtD
Idarubicin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000315	0.0019	CcSEcCtD
Idarubicin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000315	0.0019	CcSEcCtD
Idarubicin—Shock—Indinavir—acquired immunodeficiency syndrome	0.000315	0.0019	CcSEcCtD
Idarubicin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000314	0.0019	CcSEcCtD
Idarubicin—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00189	CcSEcCtD
Idarubicin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00189	CcSEcCtD
Idarubicin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000313	0.00189	CcSEcCtD
Idarubicin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000313	0.00189	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000313	0.00189	CcSEcCtD
Idarubicin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00189	CcSEcCtD
Idarubicin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00189	CcSEcCtD
Idarubicin—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00188	CcSEcCtD
Idarubicin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000312	0.00188	CcSEcCtD
Idarubicin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000311	0.00188	CcSEcCtD
Idarubicin—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00187	CcSEcCtD
Idarubicin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00031	0.00187	CcSEcCtD
Idarubicin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000308	0.00186	CcSEcCtD
Idarubicin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000308	0.00186	CcSEcCtD
Idarubicin—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00184	CcSEcCtD
Idarubicin—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000305	0.00184	CcSEcCtD
Idarubicin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.00183	CcSEcCtD
Idarubicin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000302	0.00182	CcSEcCtD
Idarubicin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.00182	CcSEcCtD
Idarubicin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.00182	CcSEcCtD
Idarubicin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.0018	CcSEcCtD
Idarubicin—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000297	0.00179	CcSEcCtD
Idarubicin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000297	0.00179	CcSEcCtD
Idarubicin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00179	CcSEcCtD
Idarubicin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.00177	CcSEcCtD
Idarubicin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00177	CcSEcCtD
Idarubicin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000292	0.00177	CcSEcCtD
Idarubicin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000291	0.00176	CcSEcCtD
Idarubicin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.00176	CcSEcCtD
Idarubicin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00029	0.00175	CcSEcCtD
Idarubicin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00174	CcSEcCtD
Idarubicin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000287	0.00173	CcSEcCtD
Idarubicin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00173	CcSEcCtD
Idarubicin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000287	0.00173	CcSEcCtD
Idarubicin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000287	0.00173	CcSEcCtD
Idarubicin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000285	0.00172	CcSEcCtD
Idarubicin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000284	0.00172	CcSEcCtD
Idarubicin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00171	CcSEcCtD
Idarubicin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000283	0.00171	CcSEcCtD
Idarubicin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.0017	CcSEcCtD
Idarubicin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000281	0.0017	CcSEcCtD
Idarubicin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.0017	CcSEcCtD
Idarubicin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00028	0.00169	CcSEcCtD
Idarubicin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.00168	CcSEcCtD
Idarubicin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000278	0.00168	CcSEcCtD
Idarubicin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00168	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000277	0.00167	CcSEcCtD
Idarubicin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.00166	CcSEcCtD
Idarubicin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000273	0.00165	CcSEcCtD
Idarubicin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.00165	CcSEcCtD
Idarubicin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00164	CcSEcCtD
Idarubicin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00164	CcSEcCtD
Idarubicin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000271	0.00164	CcSEcCtD
Idarubicin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000271	0.00163	CcSEcCtD
Idarubicin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000271	0.00163	CcSEcCtD
Idarubicin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00163	CcSEcCtD
Idarubicin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.00162	CcSEcCtD
Idarubicin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000267	0.00161	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.00161	CcSEcCtD
Idarubicin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.00159	CcSEcCtD
Idarubicin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.00159	CcSEcCtD
Idarubicin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00158	CcSEcCtD
Idarubicin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000261	0.00158	CcSEcCtD
Idarubicin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.00157	CcSEcCtD
Idarubicin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00026	0.00157	CcSEcCtD
Idarubicin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00157	CcSEcCtD
Idarubicin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.00156	CcSEcCtD
Idarubicin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.00156	CcSEcCtD
Idarubicin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000257	0.00155	CcSEcCtD
Idarubicin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00155	CcSEcCtD
Idarubicin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00154	CcSEcCtD
Idarubicin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00154	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.00154	CcSEcCtD
Idarubicin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00153	CcSEcCtD
Idarubicin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.00153	CcSEcCtD
Idarubicin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00153	CcSEcCtD
Idarubicin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00153	CcSEcCtD
Idarubicin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000252	0.00152	CcSEcCtD
Idarubicin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00152	CcSEcCtD
Idarubicin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000251	0.00152	CcSEcCtD
Idarubicin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00152	CcSEcCtD
Idarubicin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.00151	CcSEcCtD
Idarubicin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.00151	CcSEcCtD
Idarubicin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00151	CcSEcCtD
Idarubicin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000249	0.00151	CcSEcCtD
Idarubicin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000249	0.0015	CcSEcCtD
Idarubicin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000249	0.0015	CcSEcCtD
Idarubicin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000248	0.0015	CcSEcCtD
Idarubicin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000248	0.0015	CcSEcCtD
Idarubicin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000247	0.00149	CcSEcCtD
Idarubicin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000246	0.00148	CcSEcCtD
Idarubicin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000245	0.00148	CcSEcCtD
Idarubicin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00148	CcSEcCtD
Idarubicin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00148	CcSEcCtD
Idarubicin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000244	0.00147	CcSEcCtD
Idarubicin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00147	CcSEcCtD
Idarubicin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000243	0.00147	CcSEcCtD
Idarubicin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00146	CcSEcCtD
Idarubicin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00145	CcSEcCtD
Idarubicin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00145	CcSEcCtD
Idarubicin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00144	CcSEcCtD
Idarubicin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00144	CcSEcCtD
Idarubicin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00144	CcSEcCtD
Idarubicin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.00143	CcSEcCtD
Idarubicin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000236	0.00142	CcSEcCtD
Idarubicin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00142	CcSEcCtD
Idarubicin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.00142	CcSEcCtD
Idarubicin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000235	0.00142	CcSEcCtD
Idarubicin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00141	CcSEcCtD
Idarubicin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.0014	CcSEcCtD
Idarubicin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000231	0.0014	CcSEcCtD
Idarubicin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00139	CcSEcCtD
Idarubicin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00138	CcSEcCtD
Idarubicin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00138	CcSEcCtD
Idarubicin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00135	CcSEcCtD
Idarubicin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00134	CcSEcCtD
Idarubicin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00132	CcSEcCtD
Idarubicin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.00132	CcSEcCtD
Idarubicin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00132	CcSEcCtD
Idarubicin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00131	CcSEcCtD
Idarubicin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00131	CcSEcCtD
Idarubicin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.0013	CcSEcCtD
Idarubicin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00129	CcSEcCtD
Idarubicin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00129	CcSEcCtD
Idarubicin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00128	CcSEcCtD
Idarubicin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00128	CcSEcCtD
Idarubicin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00128	CcSEcCtD
Idarubicin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.00127	CcSEcCtD
Idarubicin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00125	CcSEcCtD
Idarubicin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00123	CcSEcCtD
Idarubicin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.00123	CcSEcCtD
Idarubicin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00123	CcSEcCtD
Idarubicin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00123	CcSEcCtD
Idarubicin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000203	0.00123	CcSEcCtD
Idarubicin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00122	CcSEcCtD
Idarubicin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000201	0.00122	CcSEcCtD
Idarubicin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00121	CcSEcCtD
Idarubicin—Headache—Indinavir—acquired immunodeficiency syndrome	0.0002	0.00121	CcSEcCtD
Idarubicin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Idarubicin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00119	CcSEcCtD
Idarubicin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00118	CcSEcCtD
Idarubicin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00117	CcSEcCtD
Idarubicin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00117	CcSEcCtD
Idarubicin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.00116	CcSEcCtD
Idarubicin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.00115	CcSEcCtD
Idarubicin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.00115	CcSEcCtD
Idarubicin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00019	0.00115	CcSEcCtD
Idarubicin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00114	CcSEcCtD
Idarubicin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.00114	CcSEcCtD
Idarubicin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.00111	CcSEcCtD
Idarubicin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.0011	CcSEcCtD
Idarubicin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.0011	CcSEcCtD
Idarubicin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.0011	CcSEcCtD
Idarubicin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.00109	CcSEcCtD
Idarubicin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00109	CcSEcCtD
Idarubicin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.00108	CcSEcCtD
Idarubicin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00106	CcSEcCtD
Idarubicin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.00104	CcSEcCtD
Idarubicin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.00103	CcSEcCtD
Idarubicin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00102	CcSEcCtD
Idarubicin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00102	CcSEcCtD
Idarubicin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00101	CcSEcCtD
Idarubicin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00101	CcSEcCtD
Idarubicin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000988	CcSEcCtD
Idarubicin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00098	CcSEcCtD
Idarubicin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000979	CcSEcCtD
Idarubicin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000973	CcSEcCtD
Idarubicin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000959	CcSEcCtD
Idarubicin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000942	CcSEcCtD
Idarubicin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000934	CcSEcCtD
Idarubicin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000934	CcSEcCtD
Idarubicin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000928	CcSEcCtD
Idarubicin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000923	CcSEcCtD
Idarubicin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.00088	CcSEcCtD
